Target intelligence / Profile preview

Myocardial Tissue (Refractory Period) (ERP (in the context of Myocardial Tissue))

Target
ERP (in the context of Myocardial Tissue)
Molecular classification
Electrophysiological Property, Tissue Property
01

Overview

The refractory period in myocardial tissue is the time following an action potential during which the muscle is unable, or less able, to respond to a new stimulus. It is essential for preventing tetanic contraction, limiting maximum heart rate, and preventing re-entrant arrhythmias. The absolute refractory period prevents any new action potential, while the relative refractory period allows a stronger stimulus to elicit a response. Ion channels, particularly sodium and potassium channels, are key determinants of the refractory period's duration. Many antiarrhythmic drugs target these channels to modulate the refractory period and control abnormal heart rhythms.

Other names
Cardiac Refractory PeriodVentricular Refractory PeriodAtrial Refractory PeriodEffective Refractory PeriodAbsolute Refractory PeriodRelative Refractory Period
02

Mechanism of action

Prolongation of the refractory period, typically by modulating ion channel activity (e.g., potassium channel blockade).

03

Biological functions

Regulation of heart ratePrevention of tetanic contraction in cardiac muscleCoordination of atrial and ventricular contractionsPrevention of re-entry arrhythmiasRegulation of action potential propagation
04

Disease associations

ArrhythmiaTachycardiaFibrillationHeart FailureIschemia
05

Safety considerations

Pro-arrhythmic effects (e.g., Torsades de Pointes)Excessive bradycardiaDrug-induced QT prolongation
06

Interacting drugs

Amiodarone

3 more in the full profile.

07

Biomarkers

Action Potential Duration (APD)QT interval (ECG)ERP duration

Beyond the preview

Go deeper on Myocardial Tissue (Refractory Period) (ERP (in the context of Myocardial Tissue)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myocardial Tissue (Refractory Period) (ERP (in the context of Myocardial Tissue)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call